ANNUAL MEETING DEADLINES

Abstract Submission
June 1, 2015
Early (Reduced) Registration
September 10, 2015
Advance Registration
October 20, 2015
Hotel Reservations
October 1, 2015

EXHIBITOR DEADLINES

Reduced Exhibit Rates
April 30, 2015
Regular Exhibit Rates
June 30, 2015 (based on availability)
Sponsorship Opportunities
Deadlines Vary
Advertising Opportunities
Deadlines Vary
Corporate Workshop App
July 15, 2015

AWARD APPLICATION DEADLINES

Technologist
June 1, 2015
Young Investigator
June 1, 2015
Technologist Travel
July 6, 2015
International Trainee Travel
July 31, 2015
ICPI Trainee Travel
October 5, 2015

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP

Volunteer

Mobile App Available
Brought to you by NanoString Technologies, Inc.
iphone app

AMP 2015 Annual meeting - Realizing the Dream of Precision Medicine

Scientific Program

Thank you for your interest in the AMP 2015 Annual Meeting!

Quick Links:

Thursday

Friday

Saturday

PDF of Program Mobile App

 

Tuesday, November 3, 2015

 

8:30am - 4:30pm AMP Reference Material Forum (Time to be confirmed)
9:45am - 11:15am Executive Committee Meeting (Invitation Only)
11:30am - 6:00pm Board of Directors Meeting (Invitation Only)
6:30pm Board of Directors Dinner (Invitation Only)
   

 

Wednesday, November 4, 2015

 

7:00am - 5:00pm Attendee, Speaker and Exhibitor Registration and Check-In
7:00am - 6:00pm AMP Committee Meetings(Invitation Only)
8:00am - 5:00pm Corporate Workshop Day (No registration required!)
7:30am - 3:45pm Molecular Pathology Outreach Course (MPOC) (Separate Registration)

 

Thursday, November 5, 2015

 
GENERAL INFORMATION
6:30am - 8:00am Poster Set-Up
7:00am - 6:00pm Attendee, Speaker, and Exhibitor Registration and Check-In
7:00am - 8:00am Continental Breakfast
11:30am - 4:30pm Exhibit Hall Open
   
SCIENTIFIC PROGRAM
7:00am - 8:00am EARLY BIRD SESSIONS
   
  Genomic Discoveries in Aplastic Anemia
   
   

Genomics of Aplastic Anemia

Neal S. Young, MD National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, MD, USA

   
  Training the Next Generation of Molecular Genetic Pathologists
   
   

Speakers:

Iris Schrijver, MD, Stanford University Medical Center, Stanford, CA, USA
Karen L. Kaul, MD, PhD, Northshore University HealthSystem, Evanston, IL, USA

   
  Challenging Case Studies in Solid Tumors
   
    A 38-Year Old Woman with a Rapidly-Enlarging Thigh Mass
Charlotte I. Wang, MD, PhD, Massachusetts General Hospital, Boston, MA, USA
   
    A Tale of Two ALK False Negative Lung Adenocarcinoma Cases
Damon Olson, MD, University of Colorado Denver, Aurora, CO, USA
   
    Malignancy After Solid Organ Transplantation: A Question of Tumor Origin
Suzanne R. Thibodeaux, MD, PhD, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
   
    Actionable KIT Mutation in High-Grade Neuroendocrine Carcinoma
Jason N. Rosenbaum, MD, Washington University in St. Louis, St. Louis, MO, USA
   
 

Disruptive Technologies, and Their Effect on the Traditional Molecular Diagnostics/Molecular Pathology Laboratory -- open forum discussion moderated by:

   
    Gregory J. Tsongalis, PhD, Dartmouth Hitchcock Medical Center and The Audrey and Theodor Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
   
8:00am - 8:15am Break
   
8:15am - 8:30am

Opening Remarks

Ted E. Schutzbank, PhD, AMP Program Committee Chair

   
8:30am - 9:45am

AMP Award for Excellence in Molecular Diagnostics: Presentation and Lecture

 

Imatinib as a Paradigm of Targeted Cancer Therapies
Brian J. Druker, MD, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA

   
9:45am -10:15am Coffee Break
   
10:15am - 11:45am PLENARY SESSION
  Integrating Clinical Care, Trials, and Discovery: Informatics Approaches to Clinical/Translational Harmonization
   
 

 

Enterprise-wide Clinical Sequencing to Match Patients to Personalized Cancer Treatments

Michael F. Berger, PhD, Memorial Sloan Kettering Cancer Center, New York, New York, USA

   
 


Bioinformatics and Genomic Medicine: A New Frontier for the Clinical Laboratory

Colin C. Pritchard MD, PhD, University of Washington, Seattle, WA, USA

   
11:45am - 1:00pm General Lunch - Visit Exhibit Hall and View Posters
  Specialty Lunches (schedule)
   
1:00pm - 2:30pm CONCURRENT WORKSHOPS
   
  Multiplex Testing for GI and Respiratory Infections: What Makes Sense for Your Cents?
   
   

Performance of Multiplex Panels for Detection of Gastrointestinal Pathogens

Robin Patel, MD(CM), Mayo Clinic, Rochester, MN, USA

   
    Multiplex Molecular Testing: Point-Counterpoint
Paul Schreckenberger, PhD, Loyola University Medical Center, Maywood, IL, USA
   
   

First Line Use of Multiplex PCR panels for Pathogens: Not so Fast

Alexander J. McAdam, MD, PhD, Children's Hospital Boston/Harvard Medical School, Boston, MA, USA

   
  Practical Aspects of Working with Clinical Genomic Information
   
   

Making Sense of the Human Reference Genome Assembly

Valerie Schneider, PhD, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health, Bethesda, MD, USA

   
   

RNA-DNA Differences in Human Disease

Christopher Grunseich, MD, Neurogenetics Branch, NINDS, National Institutes of Health, Bethesda, MD, USA

   
  Pharmacogenomics (PGx) Workshop
   
   

Pharmacogenomics 2015: From "Some Day" to "Today"

Howard L. McLeod, PharmD, Moffitt Cancer Center, Tampa, FL, USA

   
   

Improving Personalization of Drug Therapy: The University of Illinois Personalized Medicine Program

Julio Duarte, PhD, PharmD, University of Illinois at Chicago, Chicago, IL, USA

   
  Developing Evidence-Based Guidelines for Demonstrating Clinical Utility
   
    Overview & Introduction
Marina N. Nikiforova, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
(AMP Clinical Practice Committee Chair)
   
    Updated Guidelines for Lung Cancer Biomarkers (CAP/IASLC/AMP)
Neal I. Lindeman, MD, Brigham & Women's Hospital, Boston, MA, USA
   
    Molecular Testing Guidelines for the Selection of Colorectal Cancer Patients for Targeted and Conventional Therapies
Antonia R. Sepulveda, MD, PhD, Columbia University Medical Center, New York, NY, USA
   
    Panel Discussion
 
2:30pm - 4:15pm

Coffee Break - Visit Exhibit Hall and Posters

(Award Applicant Posters Attended)

   
4:15pm - 5:45pm CONCURRENT SYMPOSIA
   
  T-cell Immunotherapy for B-cell Neoplasms
   
   

Building Synthetic Immunity to Cancer Using Chimeric Antigen Receptors

Michael C. Milone, MD, PhD, University of Pennsylvania Health System, Philadelphia, PA, USA

   
   

Chimeric Antigen Receptor T cells for Leukemia

David M. Barrett, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, USA

   
  Validation, Implementation and Reporting NGS Assays for Oncology
   
   

Implementation of Clinical Reporting System for NGS-based Assays for Oncology: An Evolving Landscape

Somak Roy, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

   
   

Application of Targeted Next Generation Sequencing (NGS) in Clinical Oncology Studies

P. Mickey Williams, PhD, National Cancer Institute, Bethesda, MD, USA

   
5:45pm - 7:00pm Welcome Reception (Hilton Austin Hotel)
  Supported By Roche
7:00pm - 9:00pm JMD Editorial Board Dinner (Invitation Only)

 

Friday, November 6, 2015

 
GENERAL INFORMATION
7:00am - 6:00pm Attendee, Speaker, and Exhibitor Registration and Check-In
7:00am - 8:00am Continental Breakfast
9:00am - 4:00pm Exhibit Hall Open
     
SCIENTIFIC PROGRAM
7:00am - 8:00am EARLY BIRD SESSIONS
   
  Adding Value Through Molecular Diagnostics: Best Practices
   
   

The Role of a Molecular Tumor Board in Clinical Cancer Genomics

Lincoln D. Nadauld, MD, PhD, Intermountain Health Care/Medical Group, St. George, UT, USA

   
    Utilization Management Strategies in SolidTumor Molecular Testing
Joaquin J. Garcia, MD, Mayo Clinic, Rochester, MN, USA
   
  Rapid Technologies - Extreme PCR
   
   

Extreme PCR: Speed and Biochemistry

Carl T. Wittwer, MD, PhD, University of Utah, Salt Lake City, UT, USA

   
  Challenging Case Studies in Hematopathology
   
    Solving a 10-Year Old Enigma with NGS-Based Assay
Chi Young OK, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
   
    Rare p230 Fusion Gene in CML Presenting with Myeloid Sarcoma and an Isocentric Chromosome 22 in a Previously Untreated Patient
Andrea Olofson, MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
   
    Chronic Eosinophilic Leukemia with t(5;12) and ETV6-ACSL6 Fusion Gene, a Potential Mimicker of Myeloid Neoplasm with PDGFRB Rearrangement
Javier De Luca-Johnson, MD, University of Vermont Medical Center, Burlington, VT, USA
   
    Concomitant BCR-ABL1 Positive Chronic Myelogenous Leukemia Emerging in a Patient with MPL W515L Associated Primary Myelofibrosis
Juan C. Gomez-Gelvez, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
   
  Challenging Case Studies in Infectious Diseases
   
    Norovirus GII.P17-GII.17 in the Canadian Province of Nova Scotia
Michael D. Carter, MD, PhD, Dalhousie Univeristy, Halifax, Nova Scotia, Canada
   
    Pigmentiphaga Chronic Otitis Media in a 9-Year Old Girl
Ryan J. Schmidt, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA
   
    Is IHC Still a Gold Standard in the Era of Ancillary Molecular Techniques for CMV Detection?
Rugvedita Parakh, MBBS, MD, University of Washington, Seattle, WA, USA
   
  Platform Presentations of Selected Technical Topics Abstracts (7:30am Start)
   
    TT02 - Comparison of Two Next Generation Sequencing Systems: Assessment of Efficiency and Quality of Results
Pan Zhang, MD, PhD, Weill Cornell Medical College, New York, NY, USA
   
    TT04 - Orthogonal Next Generation Sequencing (NGS) of Hematologic Malignancies Using a Single Capture Library Approach
Lori A. Frederick, BS, Mayo Clinic, Rochester, MN, USA
   
8:00am - 8:15am Break
     
8:15am - 9:45am PLENARY SESSION
   
  Exciting Times for Translational Research in Molecular Hematology: Advances in Understanding Key Molecular Processes & Successful Clinical Applications of Basic Molecular Research
   
    Dnmt3a in Normal and Malignant Hematopoiesis
Margaret A. Goodell, PhD, Baylor College of Medicine, Houston, TX, USA
   
   

Targeting Intracellular Antigens Using TCR-mimic Antibodies

Gheath Al-Atrash, DO, PhD, MD Anderson Cancer Center, Houston, TX, USA

   
9:45am - 10:45am

Coffee Break - Visit Exhibit Hall and Posters

     
10:45am - 11:45am CONCURRENT WORKSHOPS: Platform Presentations of Selected Abstracts
  Abstracts are selected by the Program Committee
   
  Platform Presentations of Selected Genetics Abstracts
   
    G02 - To Confirm or Not Confirm, That is the Question: A Rigorous Approach to Evaluating the Importance of Sanger Confirmation of NGS Findings
Stephen E. Lincoln, Invitae, San Francisco, CA, USA
   
    G04 - Evaluation of CADD Scores for Identification of Pathogenic Variants in Non-coding Regions in a Germline Cancer Risk Panel
Cheryl A. Mather, MD, University of Washington, Seattle, WA, USA and University of California, San Francisco, CA ,USA
   
    G06 - The "Are You You" Assay (RUU assay): a Sensitive Method for the Detection of Sample Switching in a Clinical Massively Parallel Sequencing Laboratory
Beatrix W. Meltzer, PhD, Children's National Health System, Washington, DC, USA
   
    G08 - Hybrid Capture Probe Design to Improve Coverage Uniformity and Sensitivity of Mosaic Mutation Detection in Epilepsy Cases
Robert Daber, PhD, GeneDx, Gaithersburg, MD, USA
   
  Platform Presentations of Selected Hematopathology Abstracts
   
    H02 - Clonal Evolution of Ibrutinib Resistance in Chronic Lymphocytic Leukemia Using a 1200-gene Panel (Onco1K)
Sabah Kadri, PhD, The University of Chicago, Chicago, IL, USA
   
    H04 - Targeted Mutation Analysis Provides Evidence of Clonality in a Subset of Patients with Chronic ITP and Subsequent Monocytosis
Yen-Chun Liu, MD, PhD, Weill Cornell Medical College, New York, NY, USA
   
    H06 - Flow Cytometric Cell Sorting of Plasma and Lymphoid Cell Clones Prior to MYD88 L265P and CXCR4 Mutation Detection Improves Sensitivity and Specificity for WM/LPL Diagnosis
Barbara K. Zehentner, PhD, Hematologics, Inc., Seattle, WA, USA
   
    H08 - Accurate CALR Mutation Testing Requires Distinction of Germline In-Frame Deletions
Bryan L. Betz, PhD, University of Michigan, Ann Arbor, MI, USA
   
  Platform Presentations of Selected Infectious Diseases Abstracts
   
    ID02 - Does In-House PCR Testing Decrease Length of Stay, Hospital Costs, and Acyclovir Usage in Patients with Suspected HSV Encephalitis?
Salwa Khedr, MD, MSc, Baystate Medical Center/Tufts University, Springfield, MA, USA
   
    ID04 - 16s Metagenomic Sequencing Analysis of Gallbladder Cancer Patients in New Mexico
Rama R. Gullapalli, MD, PhD, University of New Mexico, Albuquerque, NM, USA
   
    ID06 - Assessing Laboratory Performance in the Molecular Detection of Human Papilloma Virus through International Proficiency Testing Programs
Caterina Di Lorenzo, PhD, Quality Control for Molecular Diagnostics (QCMD), Glasgow, Scotland
   
    ID08 - A Comparison of Real-time PCR to Culture Methods for Identification of Multi-Drug Resistant Organisms in Screening of ICU Patients
Barbara L. Voss, BS, NorthShore University HealthSystem, Evanston, IL, USA
   
  Platform Presentations of Informatics Selected Abstracts
   
    I02 - A Model Study of In Silico Proficiency Testing for Clinical Next Generation Sequencing
John D. Pfeifer, MD, PhD, Washington University, School of Medicine, St Louis, MO, USA
   
    I04 - Evaluation of Microsatellite Instability Detection by the MSK-IMPACT 410 Gene Hybrid-capture, NGS-based Platform
Sumit Middha, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
   
    I10 - Efficient Interpretation of Clinical Exomes Using a Network-based Approach
Chao Wu, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, USA
   
    I12 - Low-Frequency Somatic Variant Calling Through Barcoded Molecular Families Error Correction and PCR Duplicate Identification
Daniel N. Baker, MS, Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA
   
  Platform Presentations of Selected Solid Tumors Abstracts
   
    ST02 - Diagnostic Yield and Utility of RNA Sequencing in the Detection of Pathogenic Fusions in Childhood Sarcomas of Uncertain Diagnoses
Jacquelyn Reuther, PhD, Baylor College of Medicine, Houston, TX, USA
   
    ST04 - Development of Clinical Transcriptome (RNA-Seq) Analysis for Detection of Fusions and Gene Expression in Oncology Samples
Mary Beth Durso, MT(ASCP), MEd, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
   
    ST06 - Whole Exome Sequencing of Inflammatory Bowel Disease-associated Colorectal Cancer
Amy A. Lo, MD, Stanford University, Palo Alto, CA, USA
   
    ST08 - Resolution of Equivocal HER2 FISH: Reflex FISH or PCR?
Carlynn Willmore-Payne, BS, MT(ASCP), ARUP Laboratories, Salt Lake City, UT, USA
   
11:45am - 1:00pm General Lunch - Visit Exhibit Hall and View Posters
  Specialty Lunches (schedule)
   
1:00pm - 2:30pm PLENARY SESSION
   
  Microbiome in Health and Disease
   
   

The Microbiome, the Immune System and Instestinal Homeostatis: A Delicate Balance

Nita H. Salzman, MD, PhD, Medical College of Wisconsin, Milwaukee, WI, USA

   
   

The Human Microbiome in Health and Disease

George Weinstock, PhD, The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA

   
2:30pm - 3:30pm

Coffee Break - Visit Exhibit Hall and Posters

(Even-Numbered Posters Attended)

   
3:30pm - 5:00pm CONCURRENT SYMPOSIA
   
  NIPS in the Clinic - Utility of Circulating Cell-free DNA
   
   

Barriers and Promises: Non-Invasive Prenatal Screening and Prenatal Care

Anthony R. Gregg, MD, University of Florida College of Medicine, Gainesville, FL, USA

   
   

Non-invasive Prenatal Testing: Is There Scope for a True Diagnostic Test?

Brynn Levy, MSc(Med), PhD, Columbia University Medical Center & the New York Presbyterian Hospital, New York, New York, USA

   
  Coding, Coverage, and Reimbursement of Molecular Diagnostic Tests in Today's Healthcare Landscape
  Sponsored by the Economic Affairs Committee (EAC)
   
   

Economic Affairs Committee Perspective on Coding, Pricing and Reimbursement and the Genomic Sequencing Procedure Cost and Value Project

Aaron D. Bossler, MD, PhD University of Iowa College of Medicine, Iowa City, IA, USA

     
   

Reimbursement Updates: The "Real World" View

Rina Wolf, MHA Xifin, Inc. San Diego, CA, USA

     
   

NGS Reimbursement: The Risks and the Rewards

John D. Pfeifer, MD, PhD Washington University, School of Medicine, St Louis, MO, USA

     
    Working with Payers: Health Technology Assessments
Erick Lin, MD, PhD, Ambry Genetics, Aliso Viejo, DA, USA
   

 

    Panel Discussion
   
5:00pm - 5:15pm Break
   
5:15pm - 6:30pm Business Meeting and Awards Session (Open to All Registered Attendees)
   
7:00pm - 10:30pm

AMP 2015 Social Event

Luminex Welcomes AMP to Austin

 

Saturday, November 7, 2015

 
GENERAL INFORMATION
7:00am - 2:00pm Attendee, Speaker, and Exhibitor Registration and Check-In
7:00am - 8:00am Continental Breakfast
9:00am - 1:30pm Exhibit Hall Open
12:30pm - 1:30pm Poster Removal
   
SCIENTIFIC PROGRAM
7:00am - 8:00am EARLY BIRD SESSIONS
   
  Twitter 101: Social Media Benefits for the Molecular Professional
   
   

Twitter 101 Presentation and Panel Discussion


Alexis B. Carter, MD, Children's Healthcare of Atlanta, Atlanta, GA, USA
Roger D. Klein, MD, JD, The Cleveland Clinic, Foundation, Cleveland, OH, USA, PRC Chair
Federico A. Monzon, MD, Invitae, Inc., Houston, TX, USA

   
  Ethics - Points of View
   
    Ethical and Practical Considerations of LDT Regulation
Stephen P. Day, PhD, IVD Consultant, Waunakee, WI, USA
   
   

To Know or Not to Know; To Tell or Not to Tell: The Impact of Emerging Molecular Technologies on Patients, Providers and Laboratories 

Alekhya Narravula, MSc., Emory Genetics Laboratory, Atlanta, Georgia, USA

   
  To Infinity and Beyond - Toy Stories Three
   
   

Rheonix CARD Technology: The Journey of a Multipurpose Platform ®

Richard A. Montagna, PhD, FACB Rheonix, Grand Island, NY, USA

   
   

Extremely Rapid Nucleic Acid Amplification

Brian Erich Caplin, PhD, Fluoresentric, Inc., Park City, UT, USA

   
   

Metagenomic Pathogen Detection on the Oxford Nanopore Sequencer

Charles Chiu, MD, PhD, UCSF School of Medicine, San Francisco, CA, USA

   
  Phenotype-Gene Associations in Variant Interpretation
   
    Computing on Phenotypes Across Scale and Species
Christopher J. Mungall, PhD, Lawrence Berkeley National Laboratory, Berkeley, CA, USA
   
    Combining Genotype and Phenotype for Better Precision Medicine
Mark Yandell, PhD, University of Utah, Salt Lake City, UT, USA
   
  Challenging Case Studies in Genetics
   
    Towards Clinical Significance of Maternal Uniparental Disomy of Chromosome 20
Elizabeth J. Bhoj, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, USA
   
    FGFR2 Amplification in Colorectal Adenocarcinoma
Jamal H. Carter, MD, Washington University in St Louis, St. Louis, MO, USA
   
    An Uncommon WT1 Mutation and XY-Genotype Detected in 22-Year Old FFPE Tissue of a Case of Congenital Nephrotic Syndrome Caused by Denys-Drash Syndrome
Guido M.J.M. Roeman. BASc, Maastricht University Medical Center, Maastricht, The Netherlands
   
    Rescue of a Severe Skeletal Dysplasia
Pamela J. Snyder, BS, MB (ASCP), Wexner Medical Center, Columbus, OH, USA
   
8:00am - 8:15am Break
   
8:15am - 9:45am PLENARY SESSION
   
  The Expanding Role of Somatic Mosaicism in Inherited Genetic Disorders - Not Just for Cancer
   
   

Mosaicism: Two Sides of Coin

Leslie G. Biesecker, MD, National Institutes of Health, Bethesda, MD, USA

   
   

Clinical Diagnosis of Mosaic Overgrowth Syndromes Using NGS: the Power and Challenges
Marilyn M. Li, MD, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA USA

   
9:45am - 10:45am

Coffee Break - Visit Exhibit Hall and Posters

(Odd-Numbered Posters Attended)

   
10:45am - 12:15pm CONCURRENT WORKSHOPS
   
  Clinical Utility of Genomes vs Exomes vs Targeted Panels
   
   

Targeted Gene Panels vs. Exome Sequencing

Heidi L. Rehm, PhD, Brigham and Women's Hospital, Harvard Medical School, Cambridge MA, USA

   
   

Targeted Panels v. Whole Exome/Genome Analysis in Clinical Medicine

Robert L. Nussbaum, MD, Invitae

   
  Expanding the Footprint of Molecular Technologies in Clinical Labs
   
    The Molecular Evolution of Clinical Virology - One Lab's Story
Duane W. Newton, PhD, University of Michigan, Ann Arbor, MI, USA
   
   

MALDI-ToF Update - Syndromic Based Performance, Cystic Fibrosis and Beyond

Robert C. Jerris, PhD, Emory University School of Medicine, Atlanta, GA, USA

   
  Guidelines for the Interpretation of Somatic Variants
   
   

Development of Guidelines for the Interpretation of Sequence Variants in Cancer

Marilyn M. Li, MD, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA USA

   
   

Guidelines for the Interpretation of Sequence Variants in Somatic Conditions (Cancer)

Marina N. Nikiforova, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

   
  Desiderata and Implementations of Clinical Next Generation Sequencing Software -- From Samples to Reports
   
   

Clinical NGS Software - Practical Implementation Considerations

Alexis B. Carter, MD, Children's Healthcare of Atlanta, Atlanta, GA, USA

   
   

Current Challenges in NGS Data Analysis

Eric J. Duncavage, MD, Washington University, Saint Louis, MO, USA

   
   

From NGS to Bedside - Ideals and Realities of Communicating Genomic Information to Physicians

Brian Shirts, MD, PhD University of Washington, WA, USA

   
 

Modernization of CLIA Regulations for Laboratory Developed Testing Procedures (LDPs):

An Update from Washington

  Sponsored by the Professional Relations Committee (PRC)
   
   
Remarks by The Honorable Michael Burgess, U.S. House of Representatives
Congressman Michael C. Burgess
   
   

Overview of AMP's Proposal for Modernization of CLIA Regulations for LDPs
Roger D. Klein, MD, JD, The Cleveland Clinic Foundation, Cleveland, OH, USA, PRC Chair

   
    Update from Inside the Beltway on Proposed Regulatory Approaches of LDPs
Jennifer R. Leib, ScM, CGC, Health Futures, LLC, Washington, DC, USA
   
    Panel Discussion
Marc D. Grodman, MD, BioReference Laboratories, Elmwood Park, NJ, USA
Karen Kaul, MD, PHD, NorthShore University Health System, Evanston, IL, USA
Cindy Vnencak-Jones, PhD , Vanderbilt University Medical Center, Nashville, TN, USA
   
12:15pm - 1:30pm General Lunch - Visit Exhibit Hall and View Posters
  Specialty Lunches (schedule)
   
1:30pm - 3:00pm CONCURRENT SYMPOSIA
   
  Molecular Techniques for the Identification of Genetic Markers
   
   

Molecular Detection of Clinically Relevant Beta-lactamase Genes

Nancy D. Hanson, PhD, Creighton University School of Medicine, Omaha, NE, USA

   
   

Molecular Diagnostics of Thyroid Nodules: Advances and Challenges

Yuri E. Nikiforov, MD, PhD, University of Pittsburgh, Pittsburgh, PA, USA

   
  Practical Magic: Opportunities, Barriers, and the Rationale For Use of Molecular Infectious Diseases Tests At Home And Around The Globe
   
   

Rational Use of Molecular Diagnostics in Infectious Diseases

Angela M. Caliendo, MD, PhD, Brown University, Providence, RI, USA

   
   

Brighter Futures: Improving Health Through Innovative Models for the Uptake of POCTs in LMIC

Patricia J. Garcia, MD, MPH, PhD, School of Public Health and Administration (FASPA), Universidad Peruana Cayetano Heredia (UPCH), San Martín de Porres, Peru

   
3:00pm - 3:15pm Break
   
3:15pm - 4:45pm PLENARY SESSION
   
  Current Status of Precision Medicine in Oncology
   
   

Personalized Therapy for Advanced NSCLC

Roy S. Herbst, MD, PhD, Yale University, New Haven, CT, USA

   
   

Circulating Tumor DNA – Concept and Clinical Perspective

Matthias Holdhoff, MD, PhD, Johns Hopkins University School of Medicine, Baltimore, MD, USA

   
4:45pm - 5:00pm

Closing Remarks

Ted E. Schutzbank, PhD, AMP Program Committee Chair